Pannexins in Acute Kidney Injury.

ATP Acute kidney injury Adenosine Mitochondria Pannexins Purinergic signaling

Journal

Nephron
ISSN: 2235-3186
Titre abrégé: Nephron
Pays: Switzerland
ID NLM: 0331777

Informations de publication

Date de publication:
2019
Historique:
received: 25 03 2019
accepted: 03 06 2019
pubmed: 27 6 2019
medline: 2 7 2020
entrez: 27 6 2019
Statut: ppublish

Résumé

Acute kidney injury (AKI) is highly prevalent among hospitalized patients and is associated with serious consequences with limited pharmacological treatment options. Pannexin 1 (Panx1) channel is a ubiquitously expressed nonselective membrane transport channel that efficiently effluxes ATP and plays a central role in the progression of inflammatory diseases. Animal models that target Panx1 through pharmacological inhibition or genetic deficiency have better outcomes in minimizing inflammation and associated pathology. Given the involvement of Panx1 at multiple steps of -inflammatory pathology, Panx1 could be a potential therapeutic target in the treatment of AKI. Further research is needed in elaborating the mechanisms and identifying Panx1-specific inhibitor molecules to better understand the role of Panx1 in AKI pathology arising due to diverse insults.

Identifiants

pubmed: 31242494
pii: 000501278
doi: 10.1159/000501278
pmc: PMC6821569
mid: NIHMS1037807
doi:

Substances chimiques

Connexins 0
Nerve Tissue Proteins 0
PANX1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-161

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK079337
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062324
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123248
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK072922
Pays : United States

Informations de copyright

© 2019 S. Karger AG, Basel.

Références

J Clin Invest. 2012 Nov;122(11):3931-42
pubmed: 23093781
Nature. 2010 Oct 14;467(7317):863-7
pubmed: 20944749
J Gen Physiol. 2018 Jan 2;150(1):19-39
pubmed: 29233884
J Am Soc Nephrol. 2018 Jul;29(7):1887-1899
pubmed: 29866797
Contrib Nephrol. 2018;193:100-112
pubmed: 29393129
Cell Signal. 2011 Feb;23(2):305-16
pubmed: 20688156
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):289-293
pubmed: 29543788
Biochim Biophys Acta. 2013 Jan;1828(1):15-22
pubmed: 22305965
J Clin Invest. 2018 Aug 1;128(8):3583-3594
pubmed: 29894310
Nat Commun. 2015 Aug 05;6:7965
pubmed: 26242575
Curr Biol. 2000 Jun 29;10(13):R473-4
pubmed: 10898987
EMBO J. 2006 Nov 1;25(21):5071-82
pubmed: 17036048
J Vasc Res. 2012;49(5):405-16
pubmed: 22739252
FEBS Lett. 2014 Apr 17;588(8):1411-5
pubmed: 24486011
J Am Soc Nephrol. 2012 Sep;23(9):1528-37
pubmed: 22835488

Auteurs

Nabin Poudel (N)

Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.

Mark D Okusa (MD)

Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA, mdo7y@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH